01—Abstract
Summary
Summary of the 10-K filed March 1, 2021. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group (UNH) reported strong performance in its 2020 10-K filing, reflecting robust growth across its key segments despite the ongoing challenges of the COVID-19 pandemic.
The company demonstrated resilience, with total revenues increasing by 6% to $257.1 billiona and earnings from operations growing by 14% to $22.4 billion. This growth was largely driven by the UnitedHealthcare segment, which saw a 4% revenue increase, particularly benefiting from expansion in Medicare Advantage and Medicaid programs. The Optum segment was a significant contributor, with revenues surging by 21% to $136.3 billion, fueled by strong performance in OptumHealth and OptumRx.
The company maintained a healthy return on equity of 24.9% and generated substantial cash flows from operations ($22.2 billionb), underscoring its financial strength. UnitedHealth Group continued to return capital to shareholders through increased dividends and share repurchases.
While the pandemic did introduce some operational impacts, such as temporary deferral of care affecting certain service volumes, the company effectively managed these challenges through strategic customer assistance programs and cost management initiatives. Looking ahead, UNH is poised for continued growth, further supported by strategic acquisitions, including the significant pending acquisition of Change Healthcare.
02—Key points
Key Highlights
- Total revenues increased by 6% to $257.1 billion in 2020, driven by growth across both UnitedHealthcare and Optum segments.
- Earnings from operations grew by 14% to $22.4 billion, showcasing strong operational performance.
- UnitedHealthcare segment revenues increased by 4% to $200.9 billion, aided by Medicare Advantage and Medicaid enrollment growth.
- Optum segment revenues saw a significant 21% increase to $136.3 billion, propelled by OptumHealth and OptumRx.
- Return on equity remained strong at 24.9%, demonstrating effective use of shareholder capital.
- Cash flow from operations was robust at $22.2 billion, indicating strong cash generation capabilities.
- The company increased its quarterly cash dividend by 15.5% to an annual rate of $5.00 per share, signaling confidence in future performance and commitment to shareholder returns.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2020, UnitedHealth Group Inc kept $0.06.
- Revenue$257.14B100.0%
- Cost of revenue−$30.75B12.0%
- Gross profit$226.40B88.0%
- Operating costs−$203.99B79.3%
- Operating income$22.41B8.7%
- Interest, other & tax−$7.00B2.7%
- Net income$15.40B6.0%
Where FY2020 revenue went
$257.14B- Other operating costs: $162.29B, 63% of revenue
- SG&A: $41.70B, 16% of revenue
- Net income: $15.40B, 6.0% of revenue
- Cost of revenue: $30.75B, 12% of revenue
- Interest, other & tax: $7.00B, 2.7% of revenue
Kept 6.0% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2020filed March 1, 2021Financial Statements
FY2020 against FY2019
| Line item | FY2020FY2019 | Change |
|---|---|---|
| Revenue | $257.14B$242.16B | +6.2% |
| Cost of Revenue | $30.75B$28.12B | +9.3% |
| Gross Profit | $226.40B$214.04B | +5.8% |
| SG&A Expenses | $41.70B$35.19B | +18.5% |
| Operating Expenses | $234.74B$222.47B | +5.5% |
| Operating Income | $22.41B$19.68B | +13.8% |
| Interest Expense | $1.66B$1.70B | −2.4% |
| Net Income | $15.40B$13.84B | +11.3% |
| EPS (Basic) | $16.23$14.55 | +11.5% |
| EPS (Diluted) | $16.03$14.33 | +11.9% |
| Shares Outstanding (Basic) | 949.00M951.00M | −0.2% |
| Shares Outstanding (Diluted) | 961.00M966.00M | −0.5% |
05—Questions
Frequently Asked Questions
How did COVID-19 impact UnitedHealth Group's financial performance in 2020?
The COVID-19 pandemic had mixed impacts. While temporary deferral of care led to reduced volumes in some Optum businesses (like fee-for-service care delivery) and lower commercial enrollment in UnitedHealthcare, these were partially offset by increased demand for COVID-19 related care and testing, and government support programs. The company also provided significant customer assistance, which impacted results. Overall, the company demonstrated resilience, with revenue and earnings growth despite these challenges.
What is the outlook for UnitedHealthcare's Medicare Advantage and Medicaid businesses?
Both Medicare Advantage and Medicaid segments showed growth. Medicare Advantage enrollment increased due to individual plan growth, while Medicaid enrollment benefited from states easing redetermination requirements. However, Medicare Advantage faces funding pressures due to rate increases not fully matching medical cost trends, emphasizing the need for continued medical and operational cost management.
What are the key drivers of growth for the Optum segment?
The Optum segment experienced strong revenue growth driven by OptumHealth (risk-based care delivery and acquisitions) and OptumRx (pharmacy care services, specialty pharmacy, and new client wins). OptumInsight also saw growth in technology and managed services. The segment's performance highlights the company's ability to leverage technology and data analytics to improve healthcare delivery and efficiency.
How is UnitedHealth Group returning capital to shareholders?
UnitedHealth Group returned capital to shareholders through a combination of share repurchases and dividend payments. The company repurchased shares totaling $4.25 billion and increased its quarterly cash dividend by 15.5% to an annual rate of $5.00 per share, demonstrating a commitment to enhancing shareholder value.
06—Continue